Skip to Content

Notice

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. and Foreign Patents and Patent Applications Concerning Indolo [2,1-B] Quinazole-6,12-Dione Antimalarial Compounds and Methods of Treating Malaria

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Department of the Army, DOD.

ACTION:

Notice.

SUMMARY:

In accordance with 37 CFR Part 404.6 and 404.7, announcement is made of the availability for licensing of inventions set forth in the following, related patent applications:

1. Title: Indolo [2,1-B] Quinazole-6, 12-Dione Antimalarial Compounds and Methods of Treating Malaria.

U.S. Patent No.: 6,531,487.

Issued: March 11, 2003.

2. Title: Indolo [2,1-B] Quinazole-6, 12-Dione Antimalarial Compounds and Methods.

U.S. Patent No.: 6,284,772.

Issued: September 28, 1999.

Foreign rights are also available. The United States Government, as represented by the Secretary of the Army, has rights in these inventions.

ADDRESSES:

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Applications, (301) 619-6664, both at telefax (301) 619-5034.

Start Signature

Luz D. Ortiz,

Army Federal Register Liaison Officer.

End Signature End Further Info End Preamble

[FR Doc. 03-26431 Filed 10-20-03; 8:45 am]

BILLING CODE 3710-08-M